Letters Section Editor: Stephen J. Lurie,
MD, PhD, Senior Editor.
In Reply: We agree with Dr Wilcken that our
study did not "unequivocally" demonstrate clinical benefit for children with
metabolic disorders detected through expanded newborn screening, especially
as variant forms of a number of the disorders are likely to be detected.1 However, in our study the near elimination of mental
retardation in children identified by expanded newborn screening compared
with a rate of 40% in clinically identified cases attests to its benefit in
Waisbren S. Screening of Newborns for Metabolic Disorders With Mass Spectrometry—Reply. JAMA. 2004;291(12):1444. doi:10.1001/jama.291.12.1444-c
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: